‹ All Posts
Vibhu Jain

22nd Feb 2025 · SEBI-Registered Analyst

GLAXO

Glaxosmithkline Pharmaceuticals has experienced a decline of 3.36% on February 21, 2025. The stock's performance today underperformed the sector by 1.47%. During the trading session, the stock reached an intraday low of Rs 2487.55, reflecting a decrease of 3.44%. In terms of moving averages, Glaxosmithkline Pharmaceuticals is currently above the 5-day, 20-day, 50-day, and 100-day moving averages, but below the 200-day moving average. This indicates a mixed trend in the stock's performance over different time frames. Over the past day, Glaxosmithkline Pharmaceuticals Ltd recorded a performance of -2.98%, while the Sensex showed a decline of 0.56%. However, the company has seen a positive performance over the past month, with a gain of 16.68%, contrasting with the Sensex's decrease of 0.70%.

#TechnicalViews#FundamentalViews
140 likes·59 comments